Spring til hovednavigation Spring til søgning Spring til hovedindhold

The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Bidragets oversatte titel: 基于发病机制治疗遗传性神经发育障碍的未来之路
  • Ole Jakob Storebø
  • , Erlend Faltinsen
  • , Morris Zwi
  • , Erik Simonsen
  • , Christian Gluud
17 Citationer (Scopus)

Abstract

Much remains unclear about the benefits and harms of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Between 2012 and 2018, we conducted two Cochrane systematic reviews on methylphenidate for ADHD. This article explores the main findings in relation to evidence-based practice and our current understanding of ADHD.

Bidragets oversatte titel基于发病机制治疗遗传性神经发育障碍的未来之路
OriginalsprogEngelsk
TidsskriftClinical Pharmacology and Therapeutics
Vol/bind104
Udgave nummer4
Sider (fra-til)606-609
ISSN0009-9236
DOI
StatusUdgivet - 13 jul. 2018

Fingeraftryk

Dyk ned i forskningsemnerne om '基于发病机制治疗遗传性神经发育障碍的未来之路'. Sammen danner de et unikt fingeraftryk.

Citationsformater